School of Medicine
Showing 7,441-7,460 of 12,896 Results
-
Sara Michie
Professor of Pathology (Research), Emerita
Current Research and Scholarly InterestsLymphocyte/endothelial cell adhesion mechanisms involved in lymphocyte migration to sites of inflammation; regulation of expression of endothelial cell adhesion molecules.
-
Bethel Roba Mieso
Affiliate, Department Funds
Fellow in Peds/Clinical InformaticsBioDr. Mieso is a pediatrics-trained fellow in the Stanford University Clinical Informatics Fellowship Program, where she focuses on advancing child health equity and physician wellness. Her career has been marked by a commitment to addressing health disparities and advocating for systemic improvements in patient care and medical workforce conditions. She has held various leadership roles and played a crucial part in promoting diversity, equity, and inclusion (DEI) initiatives.
In her current fellowship, Dr. Mieso is leveraging her DEI expertise in clinical informatics, aiming to develop digital tools that enhance patient outcomes and experience. Her goal is to merge her informatics skills and advocacy experience to drive innovations that improve healthcare delivery, promote a more equitable and efficient system, and streamline electronic health record (EHR) systems to reduce provider burnout. Dr. Mieso holds a BS in Biology from San Jose State University, an MD from Case Western Reserve University School of Medicine, and completed her pediatrics residency at Stanford. -
Mitchell Miglis, MD
Clinical Associate Professor, Adult Neurology
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep MedicineCurrent Research and Scholarly InterestsProdromal markers of neurodegeneration in REM sleep behavior disorder
Autonomic dysfunction in Long-COVID
Postural tachycardia syndrome -
Emmanuel Mignot, MD, PhD
Craig Reynolds Professor of Sleep Medicine and Professor, by courtesy, of Genetics and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsThe research focus of the laboratory is the study of sleep and sleep disorders such as narcolepsy and Kleine Levin syndrome. We also study the neurobiological and genetic basis of the EEG and develop new tools to study sleep using nocturnal polysomnography. Approaches mostly involve human genetic studies (GWAS, sequencing), EEG signal analysis (deep learning), and immunology (narcolepsy is an autoimmune disease of the brain). We also work on autoimmune encephalitis.
-
Frederick Mihm, M.D.
Professor of Anesthesiology, Perioperative and Pain Medicine (Critical Care)
Current Research and Scholarly InterestsDr. Mihms two areas of research interest involve cardiorespiratory monitoring techniques and applications and the perioperative management of patients with pheochromocytoma.
-
Lekha Mikkilineni
Assistant Professor of Medicine (Blood and Marrow Transplantation & Cellular Therapy)
BioDr. Lekha Mikkilineni is a board-certified medical oncologist. She is also an Assistant Professor in the Department of Medicine, Division of Blood & Marrow Transplant and Cellular Therapy.
Dr. Mikkilineni has extensive experience treating blood and bone marrow cancers. She currently provides care through the Bone Marrow Transplant & Cellular Therapy Program at Stanford Health Care. Her clinical focus is multiple myeloma, plasma-cell leukemia, Extramedullary myeloma, high-risk myeloma, CAR T cell therapy, bispecific therapy, amyloidosis, POEMS syndrome, and Waldenstrom’s macroglobunemia.
Dr. Mikkilineni’s research centers on exploring novel CAR T-cell therapies to treat multiple myeloma and to define mechanisms of resistance to immunotherapy. She is particularly focused on understanding how to improve therapies for multiple myeloma patients who have extramedullary disease or high-risk features. Prior to coming to Stanford, she ran phase 1 CAR T-cell trials for multiple myeloma targeting BCMA and SLAMF7 at the National Cancer Institute.
Dr. Mikkilineni received the Conquer Cancer Foundation Young Investigator Award from the American Society of Clinical Oncology for her research focusing on SLAMF7 as a potential target for multiple myeloma. She has received honors and awards for her work at the NCI. She has completed fellowships in hematology/oncology and immunotherapy at the National Heart, Lung, and Blood Institute/National Cancer Institute. She finished her residency in internal medicine at Thomas Jefferson University Hospital. She holds a Master of Science in medical sciences from Boston University and a medical degree from Tulane University.
Dr. Mikkilineni has authored book chapters and published research in numerous high-impact academic journals. She has presented her findings through oral and poster presentations at national and international conferences. -
David Miklos
James and Katherine Lau Professor
Current Research and Scholarly InterestsDr. Miklos is the Chief of BMT & Cell Therapy Program. He leads clinical trials treating patients with lymphoma. His correlative research studies: 1) tumor antigen quantification, 2) single cell functional product characterization, 3) CAR-FACS immune phenotyping of blood and tumor, and identifying mechanisms for CAR-T treatment Failure including antigen loss, CAR-T exhaustion, and CAR suppression.
-
Christina Milcarek
Executive Administrator, Med/Stanford Center for Clinical Research
Current Role at StanfordProviding executive support to:
Dr. Kenneth Mahaffey, Founding Director, Stanford Center for Clinical Research (SCCR) -
Amin Milki, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)
Current Research and Scholarly InterestsInfertility
Assisted Reproductive Technologies Microsurgery and Endoscopic Surgery. -
Carlos Milla
Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary, Allergy and Critical Care Medicine)
Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.
